The original version of this article unfortunately contained a mistake. The presentation of the Methods in the abstract and the legend of Fig. 2 were incorrect. The corrected versions are given below.
The original version of this article unfortunately contained a mistake. The presentation of the Methods in the abstract and the legend of Fig. 2 were incorrect. The corrected versions are given below.
Methods To compare the efficacy of short-term therapy (4 days) versus standard therapy (7 days) for uncomplicated sigmoid diverticulitis, a prospective randomized multicenter trial was conducted. Patients were randomized to treatment groups after 4 days. Both patient groups were monitored until discharge and were followed up after 4-6 weeks and 52 weeks. The results were standardized and statistically evaluated. Fig. 2 Study flowchart: following enrolment in the study, 4-day therapy is first initiated with ertapenem; after investigating the success of treatment, patients are randomized to short-(4 days) or long-term therapy (7 days). Both groups continue to be monitored until discharged. Clinical examination is then conducted after 4-6 weeks and 52 weeks
